Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct Innate Immune Responses Following Inoculation With a Replicon mRNA COVID-19 Vaccine.

Microbiology and immunology·2026
Same author

Effectiveness, immunogenicity and safety of monovalent DS-5670a and bivalent DS-5670a/b SARS-CoV-2 vaccines: results from two randomized, active-comparator, non-inferiority trials.

Communications medicine·2026
Same author

Transplacental transfer of antibodies against pertussis and respiratory syncytial virus and follow-up after birth.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2025
Same author

Comparative long-term follow-up study of persistence of immunity after JVC-001 measles, mumps, and rubella vaccination in Japanese children.

Human vaccines & immunotherapeutics·2025
Same author

Evaluation of immunogenicity of mumps vaccine strains in cotton rat (Sigmodon hispidus) model.

Vaccine·2025
Same author

Immunogenicity, safety, and tolerability of a β-glucan-CpG-adjuvanted respiratory syncytial virus vaccine in Japanese healthy participants aged 60 to 80 years: A phase 2, randomized, double-blind, dose-finding study.

Human vaccines & immunotherapeutics·2025

Related Experiment Video

Updated: Jun 28, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

[Pressing issues and future plans for immunization practice in Japan].

Tetsuo Nakayama1

  • 1Laboratory of Viral Infection, Kitasato Institute for Life Sciences.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 23, 2008
PubMed
Summary
This summary is machine-generated.

Japan's 2007 measles outbreak highlighted flawed immunization strategies, driven by fear of vaccine adverse events and inflexible laws. A flexible steering committee is needed to manage immunization laws and combat infectious diseases effectively.

More Related Videos

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
06:22

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children

Published on: February 10, 2023

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

Related Experiment Videos

Last Updated: Jun 28, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
06:22

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children

Published on: February 10, 2023

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

Area of Science:

  • Public Health
  • Epidemiology
  • Immunization Policy

Context:

  • A 2007 adult measles outbreak in Japan exposed deficiencies in the national immunization strategy.
  • Fear of prosecution for vaccine adverse events hindered active immunization implementation.
  • Amendments to immunization laws post-2000 did not consistently support optimal immunization schedules.

Purpose:

  • To analyze the shortcomings of Japan's immunization strategy revealed by the 2007 measles outbreak.
  • To examine the impact of legal frameworks and fear of adverse events on vaccine program implementation.
  • To propose improvements for managing immunization laws and strategies in response to infectious disease threats.

Summary:

  • The 2007 measles outbreak underscored issues with vaccine adverse event management and legal inflexibility in Japan's immunization program.
  • The discontinuation of the Japanese encephalitis vaccine recommendation following adverse events exemplifies long-term prevention failures.
  • A lack of adaptable legal structures and a tendency to avoid responsibility were identified as critical problems.

Impact:

  • Highlights the need for a more flexible approach to managing immunization laws and policies.
  • Suggests the establishment of a dedicated steering committee to adapt strategies for infectious disease control.
  • Emphasizes the importance of balancing vaccine safety concerns with public health protection goals.